Featured Post

APA 2026: Real-World Gaps in GAD Care and Early Safety Data for DT120

July 27, 2026

APA 2026 data show GAD treatment cycling is common, while preclinical DT120 studies address cardiac and dependence safety concerns for this 5-HT2A agonist.
 Read More

Other top stories

Psychedelics Are Advancing in GAD, but None Are Yet Approved

July 16, 2026

Beyond SSRIs: Why the Next Advance in GAD May Not Target Monoamines

July 7, 2026

Generalized Anxiety Disorder: A Persistent Burden and a New Look at Psychedelics

July 7, 2026

The latest news on Psychopharmacology

Other stories

Why Your Psychiatric Patients Aren’t Sleeping: CBT-I and a Pathway That Finally Works

March 30, 2026

The Sleep Disorder You Are Missing in Your Psychiatric Patients & The Modern Solution For It

March 11, 2026

Brain Training Could Delay Dementia for Years

February 11, 2026

Psychosis Soars in Younger Generations

February 10, 2026

Ketogenic Diet Shows Modest Mental Health Benefits

February 9, 2026

Group Exercise Delivers Mental Health Gains

February 6, 2026

Learn More About Psychedelics in Psychiatry

Explore the Collection
Neural network illustration symbolizing psychedelic research advancements

Subscribe to read
more articles

Subscribe